Relationship of environmental exposures to the clinical phenotype of sarcoidosis

Chest

Volumn 128, Issue 1, 2005, Pages 207-215

  Kreider, Mary Elizabeth ^a,f   Christie, Jason D ^a   Thompson, Bruce ^b   Newman, Lee ^c   Rose, Cecile ^c   Barnard, Juliana ^c   Bresnitz, Eddy ^d   Judson, Marc A ^e   Lackland, Daniel T ^e   Rossman, Milton D ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Clinical Trials & Surveys Corp   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Environmental exposures; Epidemiology; Organic dust; Race; Wood smoke

Indexed keywords

ACID FAST BACTERIUM; ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; COMBUSTION; DUST; ENVIRONMENTAL EXPOSURE; FEMALE; FUNGUS; GRANULOMATOSIS; HISTOPATHOLOGY; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OCCUPATIONAL EXPOSURE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SARCOIDOSIS; STATISTICAL SIGNIFICANCE; SYMPTOM; UNITED STATES; WOOD;

EID: 22244483107     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.1.207     Document Type: Article

References (29)

1. Newman LS, Rose CS, Maier LA. Medical progress: sarcoidosis. N Engl J Med 1997; 336:1224-1234
2. American Thoracic Society, The European Respiratory Society, The World Association of Sarcoidosis and other Granulomatous Disorders. Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160:736-755
3. Heyll A, Meckenstock G, Aul C, et al. Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14:161-164
4. ACCESS Research Group. Design of a case control etiologic study of sarcoidosis. J Clin Epidemiol 1999; 52:1173-1186
5. Judson MA, Baughman RP, Teirstein A, et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:75-86
6. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004; 170:1268-1269
7. Kelsey J, Thompson W, Evans A. Methods in observational epidemiology. New York, NY; Oxford University Press, 1986
8. Kleinbaum D, Kupper L, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, CA: Lifetime Learning Publications, 1982
9. Greenland S. Tests for interaction in epidemiologic studies: a review and study of power. Stat Med 1983; 2:243-251
10. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993; 138:923-936
11. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129:125-137
12. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. AJR Am J Roentgenol 2001; 164:1885-1889
13. Edmondstone WM. Sarcoidosis in nurses: is there an association? Thorax 1988; 43:342-343
14. National Institute for Occupational Safety and Health. Sarcoidosis among US Navy enlisted men, 1965-1993. MMWR Morb Mortal Wkly Rep 1997; 46:539-543
15. Kern D, Neill M, Wrenn D, et al. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis 1993; 148:974-980
16. Parkes S, Baker S, Bourdillon R, et al. Epidemiology of sarcoidosis in the Isle of Man: 1. A case controlled study. Thorax 1987; 42:420-426
17. Hills S, Parkes S, Baker S. Epidemiology of sarcoidosis in the Isle of Man: 2. Evidence for space-time clustering. Thorax 1987; 42:427-430
18. McDonough C, Gray G. Risk factors for sarcoidosis hospitalization among US Navy and Marine Corps personnel, 1981 to 1995. Mil Med 2000; 165:630-632
19. Kajdasz DK, Lackland DT, Mohr LCJ, et al. A current assessment of rurally linked exposures a potential risk factors for sarcoidosis. Ann Epidemiol 2001; 11:111-117
20. Terris M, Chaves AD. An epidemiologic study of sarcoidosis. Am Rev Respir Dis 1966; 94:50-55
21. Sartwell P, Edwards L. Epidemiology of sarcoidosis in the U.S. Navy. Am J Epidemiol 1974; 99:250-257
22. Kajdasz DK, Judson MA, Mohr LCJ, et al. Geographic variations in the prevalence of sarcoidosis in South Carolina: its relationship to socioeconomic status and health care indicators. Am J Epidemiol 1999; 150:271-278
23. Herody M, Bobrie G, Gouarin C, et al. Anti-GBM disease: predictive value of clinical histological and serological data. Clin Nephrol 1993; 40:249-255
24. Donaghy M, Rees AJ. Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membranes. Lancet 1983; 2:1390-1393
25. Bombassei GJ, Kaplan A. The association between hydrocarbon exposure and anti-glomerular basement membrane antibody-mediated disease (Goodpasture's syndrome). Am J Ind Med 1992; 21:141-153
26. Rybicki B, Major M, Popovich J, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145:234-241
27. Keller AZ. Hospital, age, racial, occupational, geographical, clinical and survivorship characteristics in the epidemiology of sarcoidosis. Am J Epidemiol 1971; 94:222-230
28. Hillerdal G, Nou E, Osterman K, et al. Sarcoidosis: epidemiology and prognosis; a 15-year European study. Am Rev Respir Dis 1984; 133:97-103
29. Judson M, Baughman R, Thompson B, et al. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20:204-211